Literature DB >> 22249297

Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Eline L M Op de Coul1, Hannelore M Götz, Jan E A M van Bergen, Johannes S A Fennema, Christian J P A Hoebe, Rik H Koekenbier, Lydia L Pars, Sander M van Ravesteijn, Marianne A B van der Sande, Ingrid V F van den Broek.   

Abstract

BACKGROUND: In the Netherlands, an Internet-based Chlamydia Screening Implementation was initiated in 3 regions, aiming to reduce population prevalence by annual testing and treatment of people aged 16 to 29 years. We studied who was reached in the first screening round by relating participation and chlamydia positivity to sociodemographic and sexual risk factors.
METHODS: Data from the 2008/2009 screening round were analyzed (261,025 screening invitations, 41,638 participants). Participation rates were adjusted for the sexually active population. Sociodemographic and behavioral correlates of screening participation and positivity were studied by (multilevel) logistic regression models.
RESULTS: The overall adjusted participation rate in the first screening round was 19.5% (95% confidence interval, 19.4-19.7) among sexually active people (women, 25%; men, 13%). Sociodemographic factors associated with lower participation were male gender (odds ratio [OR], male 1 vs. female 1.8), young age (OR, 16-19 1 vs. older groups 1.7-2.1), non-Dutch origin (OR between 0.7-0.9), lower education (OR, low 1 vs. high 1.4), high community risk level (0.8), and low socioeconomic status (0.9). Behavioral factors associated with lower participation were a long-standing relationship (0.7) and no reported history or symptoms of sexually transmitted infections (no symptoms, 0.4-0.6) . Factors most strongly related to higher Ct positivity were young age (OR, 1 vs. older groups 0.5-0.8), non-Dutch origin (1.4-2.8), non-Dutch steady partner (1.9-2.7), residence in a high-risk area (1.4-1.5), lower education (high, 0.3-0.5), and a history or symptoms of sexually transmitted infection (no symptoms, 0.4-0.6).
CONCLUSIONS: Sociodemographic factors associated with lower participation were also associated with higher Ct positivity, showing that high-risk demographic groups are more difficult to mobilize than low-risk groups. Independent of this, higher behavioral risk levels were associated with higher participation rates, suggesting self-selection for screening based on the persons' risk (perception) in both low- and high community risk groups. Our study shows the complexity of the process, including individual and community factors that also interact, when screening for chlamydia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249297     DOI: 10.1097/OLQ.0b013e3182383097

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Counseling to reduce high-risk sexual behavior in HIV care: a multi-center, direct observation study.

Authors:  Tabor E Flickinger; Stephen Berry; P Todd Korthuis; Somnath Saha; M Barton Laws; Victoria Sharp; Richard D Moore; Mary Catherine Beach
Journal:  AIDS Patient Care STDS       Date:  2013-06-26       Impact factor: 5.078

2.  Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

Authors:  Ingrid V F van den Broek; Jan E A M van Bergen; Elfi E H G Brouwers; Johannes S A Fennema; Hannelore M Götz; Christian J P A Hoebe; Rik H Koekenbier; Mirjam Kretzschmar; Eelco A B Over; Boris V Schmid; Lydia L Pars; Sander M van Ravesteijn; Marianne A B van der Sande; G Ardine de Wit; Nicola Low; Eline L M Op de Coul
Journal:  BMJ       Date:  2012-07-05

3.  Higher Chlamydia trachomatis prevalence in ethnic minorities does not always reflect higher sexual risk behaviour.

Authors:  Amy Matser; Nancy Luu; Ronald Geskus; Titia Heijman; Marlies Heiligenberg; Maaike van Veen; Maarten Schim van der Loeff
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

4.  Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Authors:  Nynke F B Dokkum; Rik H Koekenbier; Ingrid V F van den Broek; Jan E A M van Bergen; Elfi E H G Brouwers; Johannes S A Fennema; Hannelore M Götz; Christian J P A Hoebe; Lydia L Pars; Sander M van Ravesteijn; Eline L M Op de Coul
Journal:  BMC Public Health       Date:  2012-03-09       Impact factor: 3.295

5.  Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy.

Authors:  Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

6.  Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices.

Authors:  Petra J Woestenberg; Aloysia A M van Oeffelen; Irina Stirbu-Wagner; Birgit H B van Benthem; Jan E A M van Bergen; Ingrid V F van den Broek
Journal:  BMC Fam Pract       Date:  2015-06-18       Impact factor: 2.497

7.  Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.

Authors:  Eline L M Op de Coul; Demi Peek; Yolanda W M van Weert; Servaas A Morré; Ingrid Rours; Chantal Hukkelhoven; Ank de Jonge; Birgit van Benthem; Monique Pereboom
Journal:  Reprod Health       Date:  2021-06-26       Impact factor: 3.223

8.  Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Authors:  Boris V Schmid; Eelco A B Over; Ingrid V F van den Broek; Eline L M Op de Coul; Jan E A M van Bergen; Johan S A Fennema; Hannelore M Götz; Christian J P A Hoebe; G Ardine de Wit; Marianne A B van der Sande; Mirjam E E Kretzschmar
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Serogroup distribution of urogenital Chlamydia trachomatis in urban ethnic groups in The Netherlands.

Authors:  S P Verweij; K D Quint; C J Bax; A P Van Leeuwen; J A E M Mutsaers; C L Jansen; P M Oostvogel; S Ouburg; S A Morré; R P H Peters
Journal:  Epidemiol Infect       Date:  2013-04-24       Impact factor: 4.434

10.  Factors associated with Chlamydia trachomatis testing in a high school based screening and previously in clinical practice: a cross-sectional study in Norway.

Authors:  Kirsten Gravningen; Gunnar Skov Simonsen; Anne-Sofie Furberg; Tom Wilsgaard
Journal:  BMC Infect Dis       Date:  2013-08-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.